Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Communications and Networking in Education by

bigCover of the book Computer-Supported Collaborative Learning at the Workplace by

bigCover of the book Vitiligo and Other Hypomelanoses of Hair and Skin by

bigCover of the book MEMS Linear and Nonlinear Statics and Dynamics by

bigCover of the book Sensory Coding in the Mammalian Nervous System by

bigCover of the book Time Pressure and Stress in Human Judgment and Decision Making by

bigCover of the book Modeling and Control of Antennas and Telescopes by

bigCover of the book Ethics in Hard Times by

bigCover of the book Improving Democracy Through Constitutional Reform by

bigCover of the book Therapy of Renal Diseases and Related Disorders by

bigCover of the book VLSI for Wireless Communication by

bigCover of the book World Economic Issues at the United Nations by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy